Adverse drug reactions and adverse drug events associated with use of psychotropic, antiepileptic, antihypertensive and antidiabetic drugs in pregnancy

[1]  Momina Zulfeen,et al.  IV labetalol and oral nifedipine in acute control of severe hypertension in pregnancy-A randomized controlled trial. , 2019, European journal of obstetrics, gynecology, and reproductive biology.

[2]  J. Dodd,et al.  Effect of metformin in addition to dietary and lifestyle advice for pregnant women who are overweight or obese: the GRoW randomised, double-blind, placebo-controlled trial. , 2019, The lancet. Diabetes & endocrinology.

[3]  L. Mâsse,et al.  A 6-year longitudinal study: Are maternal depressive symptoms and Selective Serotonin Reuptake Inhibitor (SSRI) antidepressant treatment during pregnancy associated with everyday measures of executive function in young children? , 2019, Early human development.

[4]  S. Reif,et al.  Prenatal exposure to selective serotonin reuptake inhibitors and serotonin norepinephrine reuptake inhibitors and risk for persistent pulmonary hypertension of the newborn: a systematic review, meta‐analysis, and network meta‐analysis , 2019, American journal of obstetrics and gynecology.

[5]  A. Abou-Samra,et al.  Metformin-treated-GDM has lower risk of macrosomia compared to diet-treated GDM- a retrospective cohort study , 2020, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[6]  T. Coleman,et al.  Systematic Review and Meta-Analysis to Assess the Safety of Buproprion and Varenicline in Pregnancy. , 2019, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[7]  Robert W. Li,et al.  The valproic acid rat model of autism presents with gut bacterial dysbiosis similar to that in human autism , 2018, Molecular Autism.

[8]  V. Bergink,et al.  Lithium during pregnancy and after delivery: a review , 2018, International Journal of Bipolar Disorders.

[9]  A. Nayak,et al.  Risk analysis of suicidal ideations and postpartum depression with antenatal alpha methyldopa use. , 2018, Asian journal of psychiatry.

[10]  Y. Hauck,et al.  The Relationship Between Pregnancy Exposure to Antidepressant and Atypical Antipsychotic Medications and Placental Weight and Birth Weight Ratio: A Retrospective Cohort Study , 2018, Journal of clinical psychopharmacology.

[11]  Su-xia Cao,et al.  A meta-analysis of selective serotonin reuptake inhibitors (SSRIs) use during prenatal depression and risk of low birth weight and small for gestational age. , 2018, Journal of affective disorders.

[12]  Yuhong Zhao,et al.  Selective serotonin reuptake inhibitor use during early pregnancy and congenital malformations: a systematic review and meta-analysis of cohort studies of more than 9 million births , 2018, BMC Medicine.

[13]  Stuart J. Watson,et al.  Aripiprazole and pregnancy: A retrospective, multicentre study. , 2018, Journal of affective disorders.

[14]  Naymee Velez-Ruiz.  More than Meets the Eye: Antiepileptic Drug Use during Pregnancy and its Effects beyond Teratogenesis , 2018, Epilepsy currents.

[15]  G. Koren,et al.  Clinical implications of selective serotonin reuptake inhibitors-selective serotonin norepinephrine reuptake inhibitors pharmacogenetics during pregnancy and lactation. , 2018, Pharmacogenomics.

[16]  K. Wisner,et al.  Treatment of Peripartum Bipolar Disorder. , 2018, Obstetrics and gynecology clinics of North America.

[17]  S. Meltzer-Brody,et al.  Pharmacologic Treatment of Perinatal Depression. , 2018, Obstetrics and gynecology clinics of North America.

[18]  S. Hernández-Díaz,et al.  Risk of Major Malformations in Infants Following First-Trimester Exposure to Quetiapine. , 2018, The American journal of psychiatry.

[19]  T. Heinbockel,et al.  6 Hz Active Anticonvulsant Fluorinated N-Benzamide Enaminones and Their Inhibitory Neuronal Activity , 2018, International journal of environmental research and public health.

[20]  M. Blennow,et al.  MAGDALENA: study protocol of a randomised, placebo-controlled trial on cognitive development at 2 years of age in children exposed to SSRI in utero , 2018, BMJ Open.

[21]  Seonjoo Lee,et al.  Major depressive disorder during pregnancy: Psychiatric medications have minimal effects on the fetus and infant yet development is compromised , 2018, Development and Psychopathology.

[22]  Clare L. Taylor,et al.  Maternal and infant outcomes associated with lithium use in pregnancy: an international collaborative meta-analysis of six cohort studies. , 2018, The lancet. Psychiatry.

[23]  M. Hoeltzenbein,et al.  Increased rate of birth defects after first trimester use of angiotensin converting enzyme inhibitors - Treatment or hypertension related? An observational cohort study. , 2018, Pregnancy hypertension.

[24]  M. Loane,et al.  Metformin exposure in first trimester of pregnancy and risk of all or specific congenital anomalies: exploratory case-control study , 2018, British Medical Journal.

[25]  Sabine J. Roza,et al.  Long-term neurodevelopmental consequences of intrauterine exposure to lithium and antipsychotics: a systematic review and meta-analysis , 2018, European Child & Adolescent Psychiatry.

[26]  T. Greenhalgh,et al.  Sodium valproate in pregnancy: what are the risks and should we use a shared decision-making approach? , 2018, BMC Pregnancy and Childbirth.

[27]  S. Kochen,et al.  Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry , 2018, The Lancet Neurology.

[28]  T. Laursen,et al.  Association Between Prenatal Valproate Exposure and Performance on Standardized Language and Mathematics Tests in School-aged Children , 2018, JAMA neurology.

[29]  C. Andrade.  Valproate in Pregnancy: Recent Research and Regulatory Responses. , 2018, The Journal of clinical psychiatry.

[30]  M. Postma,et al.  Antidepressant use during pregnancy and the risk of developing gestational hypertension: a retrospective cohort study , 2018, BMC Pregnancy and Childbirth.

[31]  E. Denny,et al.  AntiEpileptic drug Monitoring in PREgnancy (EMPiRE): a double-blind randomised trial on effectiveness and acceptability of monitoring strategies. , 2018, Health technology assessment.

[32]  S. Hernández-Díaz,et al.  Continuation of Atypical Antipsychotic Medication During Early Pregnancy and the Risk of Gestational Diabetes. , 2018, The American journal of psychiatry.

[33]  H. Affres,et al.  Effect of Glyburide vs Subcutaneous Insulin on Perinatal Complications Among Women With Gestational Diabetes: A Randomized Clinical Trial , 2018, JAMA.

[34]  M. Werler,et al.  Metformin in the first trimester and risks for specific birth defects in the National Birth Defects Prevention Study. , 2018, Birth defects research.

[35]  F. Groenendaal,et al.  Neonatal Hypoglycemia Following Diet-Controlled and Insulin-Treated Gestational Diabetes Mellitus , 2018, Diabetes Care.

[36]  Edmundo Santos,et al.  Low-dose warfarin maternal anticoagulation and fetal warfarin syndrome , 2018, BMJ Case Reports.

[37]  P. Videbech,et al.  The Safety of Second-Generation Antipsychotics During Pregnancy: A Clinically Focused Review , 2018, CNS Drugs.

[38]  Junrong Ren,et al.  Transcriptional and splicing dysregulation in the prefrontal cortex in valproic acid rat model of autism. , 2018, Reproductive toxicology.

[39]  Ø. Salvesen,et al.  Metformin Use in PCOS Pregnancies Increases the Risk of Offspring Overweight at 4 Years of Age: Follow-Up of Two RCTs , 2018, The Journal of clinical endocrinology and metabolism.

[40]  R. Margis,et al.  Behavioral alterations in autism model induced by valproic acid and translational analysis of circulating microRNA. , 2018, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[41]  A. Fagiolini,et al.  Aripiprazole use during pregnancy, peripartum and lactation. A systematic literature search and review to inform clinical practice. , 2018, Journal of affective disorders.

[42]  P. Sarma,et al.  Teratogenicity of antiepileptic dual therapy , 2018, Neurology.

[43]  M. Loane,et al.  Insulin analogues use in pregnancy among women with pregestational diabetes mellitus and risk of congenital anomaly: a retrospective population-based cohort study , 2018, BMJ Open.

[44]  P. Campolongo,et al.  Impaired repair of DNA damage is associated with autistic-like traits in rats prenatally exposed to valproic acid , 2018, European Neuropsychopharmacology.

[45]  S. Skurtveit,et al.  Effect of Time-Dependent Selective Serotonin Reuptake Inhibitor Antidepressants During Pregnancy on Behavioral, Emotional, and Social Development in Preschool-Aged Children , 2017, Journal of the American Academy of Child and Adolescent Psychiatry.

[46]  E. Molden,et al.  Treatment With Antipsychotics in Pregnancy: Changes in Drug Disposition , 2017, Clinical pharmacology and therapeutics.

[47]  D. Reith,et al.  Antiepileptic drug exposure in pregnancy and pregnancy outcome from national drug usage data , 2017, BMC Pregnancy and Childbirth.

[48]  Dana R. Fasanella,et al.  Use of Antidiabetic, Antihypertensive, and Psychotropic Drugs in Pregnancy , 2018 .

[49]  I. Pérez López-Fraile,et al.  Comparative study of antiepileptic drug use during pregnancy over a period of 12 years in Spain. Efficacy of the newer antiepileptic drugs lamotrigine, levetiracetam, and oxcarbazepine. , 2018, Neurologia.

[50]  Itai Berger,et al.  Short‐ and long‐term complications of in utero exposure to lamotrigine , 2018, British journal of clinical pharmacology.

[51]  M. Browne,et al.  Maternal Hypertension, Antihypertensive Medication Use, and Small for Gestational Age Births in the National Birth Defects Prevention Study, 1997–2011 , 2018, Maternal and Child Health Journal.

[52]  M. Loane,et al.  Beta-Blocker Use in Pregnancy and Risk of Specific Congenital Anomalies: A European Case-Malformed Control Study , 2017, Drug Safety.

[53]  L. I. Borges,et al.  In utero and lactational exposure to metformin induces reproductive alterations in male rat offspring. , 2017, Reproductive toxicology.

[54]  F. Hu,et al.  Adiposity, Dysmetabolic Traits, and Earlier Onset of Female Puberty in Adolescent Offspring of Women With Gestational Diabetes Mellitus: A Clinical Study Within the Danish National Birth Cohort , 2017, Diabetes Care.

[55]  Weiwei Zhu,et al.  Comparison of anticoagulation regimens for pregnant women with prosthetic heart valves: A meta‐analysis of prospective studies , 2017, Cardiovascular therapeutics.

[56]  Ahmed Elmaraezy,et al.  Effect of metformin on maternal and neonatal outcomes in pregnant obese non-diabetic women: A meta-analysis , 2017, International journal of reproductive biomedicine.

[57]  M. Guerrero.  AbstractCommittee Opinion No.692: Emergent Therapy for Acute-Onset, Severe Hypertension During Pregnancy and the Postpartum Period: ACOG Committee on Obstetrics Practice Obstet Gynecol. 2017;129(4):e90-95 , 2017 .

[58]  M. Hoeltzenbein,et al.  Pregnancy Outcome After First Trimester Use of Methyldopa: A Prospective Cohort Study , 2017, Hypertension.

[59]  A. Tricco,et al.  Comparative safety of anti-epileptic drugs during pregnancy: a systematic review and network meta-analysis of congenital malformations and prenatal outcomes , 2017, BMC Medicine.

[60]  M. Werler,et al.  Maternal Antihypertensive Medication Use and Congenital Heart DefectsNovelty and Significance , 2017 .

[61]  H. Çaksen,et al.  Fetal Valproate Syndrome. , 2017, Pediatrics and neonatology.

[62]  Committee Opinion No. 692: Emergent Therapy for Acute-Onset, Severe Hypertension During Pregnancy and the Postpartum Period. , 2017, Obstetrics and gynecology.

[63]  Jia Yao,et al.  Upper extremity prosthesis user perspectives on unmet needs and innovative technology , 2016, EMBC.

[64]  I. Pérez López-Fraile,et al.  Comparative study of antiepileptic drug use during pregnancy over a period of 12 years in Spain. Efficacy of the newer antiepileptic drugs lamotrigine, levetiracetam, and oxcarbazepine. , 2016, Neurologia.

[65]  M. Clementi,et al.  First-trimester exposure to metformin and risk of birth defects: a systematic review and meta-analysis. , 2014, Human reproduction update.

[66]  K. Meador,et al.  Antiepileptic drug clearance and seizure frequency during pregnancy in women with epilepsy , 2013, Epilepsy & Behavior.

[67]  M. Martinussen,et al.  Metformin's Effect on First-Year Weight Gain: A Follow-up Study , 2012, Pediatrics.

[68]  S. Carlsen,et al.  Growth, body composition and metabolic profile of 8-year-old children exposed to metformin in utero , 2012, Scandinavian journal of clinical and laboratory investigation.

[69]  D. Veenstra,et al.  VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. , 2012, Chest.

[70]  F. Kashfi,et al.  Anti-Coagulation During Pregnancy in Women with Mechanical Heart Valves: A Prospective Study , 2011, International journal of fertility & sterility.

[71]  H. Saeid,et al.  Anti-coagulation during pregnancy in women with mechanical heart valves: a prospective study. , 2011 .

[72]  P. Romundstad,et al.  Metformin versus placebo from first trimester to delivery in polycystic ovary syndrome: a randomized, controlled multicenter study. , 2010, The Journal of clinical endocrinology and metabolism.

[73]  M. Werler,et al.  Antihypertensive Medication Use During Pregnancy and the Risk of Cardiovascular Malformations , 2009, Hypertension.

[74]  K. Salvesen,et al.  Metformin reduces pregnancy complications without affecting androgen levels in pregnant polycystic ovary syndrome women: results of a randomized study. , 2004, Human reproduction.

[75]  D. Wlody,et al.  Hypertension in pregnancy. , 1992, The New England journal of medicine.